American Oriental Bioengineering Inc. to Present at the ICR XChange Asia Institutional Investor Conference.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- American Oriental Bioengineering bioengineering Application of engineering principles and equipment to biology and medicine. It includes the development and fabrication of life-support systems for underwater and space exploration, devices for medical treatment (see Inc. (AMEX AMEX See: American Stock Exchange : AOB AOB (on the agenda for a meeting) any other business ), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products in China, today announced that the company will present at the ICR (Intelligent Character Recognition or Image Character Recognition) The machine recognition of hand-printed characters as well as machine printing that is difficult to recognize. XChange Asia institutional investor Institutional Investor A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions. conference on October 3, 2006 at the Reuters Conference Center in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Management's presentation will begin at 11:00 a.m. ET at the Reuters Conference Center located at Three Times Square in New York City. Management will host a break-out session with investors immediately following the presentation. At 4:00 pm ET, ICR XChange Asia presenting companies will close the market live on television at the NASDAQ MarketSite. To register for the ICR XChange Asia please visit www.icrxchange.com or contact Ashley M. Ammon at 203-682-8200. About American Oriental Bioengineering Inc. American Oriental Bioengineering Inc. (AOB) is engaged in the development and production of plant-based pharmaceutical products and plant-based nutraceutical products widely distributed throughout China. For more information, visit http://www.bioaobo.com. About ICR XChange Asia The ICR XChange now introduces Asia-based, publicly-traded companies to key Wall Street constituents: investors, analysts, bankers and capital markets professionals. The ICR XChange Asia brings ICR's existing annual conference to the increasingly popular Asian marketplace. This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion